Epstein-Barr Virus Infection and Increased Sporadic Breast Carcinoma Risk: A Meta-Analysis.
The association of Epstein-Barr virus (EBV) infection with breast carcinoma (BC) risk is disputed in the literature so far. Therefore, we performed a meta-analysis to clarify this relationship. An electronic database search for eligible case-control studies was performed using Pubmed, Embase, Web of Science, Cochrane, CNKI and WANFANG until May 17, 2018. The pooled odds ratio (OR) and 95% confidence interval (95% CI) were used to estimate the relationship between EBV infection and BC risk using a fixed or random-effects model depending on heterogeneity. Subgroup analysis and meta regression were used to explore the heterogeneity. Publication bias was assessed using Egger's and Harbord's tests. A total of sixteen studies with 1279 patients and 814 controls were reviewed based on our inclusion and exclusion criteria. Compared with the control group, EBV infection had a significant association with BC risk (OR = 4.75, 95% CI = 2.53-8.92, p < 0.01) with significant heterogeneity observed (I2 = 65.3%). Subgroup analysis revealed that region and tissue type might explain potential sources of heterogeneity. Sensitivity analyses yielded stable results. No significant publication bias was observed. The current results suggest that EBV infection is significantly associated with increased risk of BC. <br> <br>.